CENTER OF MOLECULAR IMMUNOLOGY(CIM).CIMAB

Trials shown by sponsor

Public title	Date of Registration	State
Therapeutic Equivalence between ior EPOCIM and EPO without albumin, for patients with Chronic Renal failure on Peritoneal dialysis methods.(Hemodialysis or peritoneal dialysis).	2009-07-03	Registered
Study of intensive pediatric pharmacovigilance of nimotuzumab for the treatment of malignant glioma tumors.	14/08/2014	Registered
Safety evaluation of Recombinant Human Erythropoietin ior EPOCIM in the treatment of patient with cerebral infarction acute. Study Stage I.	2009-07-03	Registered outdated
Safety assessment of Granulocyte Colony Stimulating Factor:ior LeukoCIM in oncohematologic patients.Phase IV study.	2009-07-24	Registered
Nimotuzumab- Head and neck cancer	2009-10-22	Registered
Nimotuzumab in tumors of head and neck .Phase IV	2013-02-01	Registered
Nimotuzumab for the treatment of high grade of malignancy tumors	2013-02-01	Registered
NeuroEPO-Stroke. Phase I-II	11/09/2014	Registered
NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II	02/11/2014	Registered
NeuroEPO in healthy volunteers.	2013-06-10	Registered
iorEPOCIM-Stroke-Phase I	2012-09-17	Registered outdated
ior ®EPOCIM as a cardioprotective agent in the surgery of rheumatic valvular disease.	26/08/2013	Registered outdated
ior EPOCIM ® in the management of anemia of the preterm infant.Phase IV.	2013-02-26	Registered
Impact of the Granulocytes Colony-Stimulating Factor (ior-LeukoCIM) in primary and secondary prophylaxis and post chemotherapy and/or radiotherapy neutropenia in oncohematological pediatric patients.	2009-07-24	Registered
Impact of Recombinant Human Erythropoietin (ior EPO-CIM) in oncology pediatric patients with post chemo and /or radiotherapy.	2009-07-03	Registered
Impact of Human Recombinant Erithoropoietin (ior EPOCIM) in cancer patients with post Chemo and Radiotherapy induced anemia.	2009-07-03	Registered
EPOCIM in benign prostatic hyperplasia.	2009-10-23	Registered
Effectiveness and Safety of Nimotuzumab for the treatment of patients with glioma tumors	2009-09-18	Registered
Effectiveness and safety of ior®EPOCIM in Chronic Kidney Disease patients in pre-dialysis.	2011-11-11	Registered
Effectiveness and Safety of ior EPOCIM in patients with Chronic Renal Failure on dialysis methods.	2009-07-10	Registered

Registered Trials

Registration process

CENTER OF MOLECULAR IMMUNOLOGY(CIM).CIMAB

About the RPCEC

Useful resources